Oncoinvent ASA
ONCIN
Rangering i aksjer
#27370
Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to... Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to developing innovative radiopharmaceutical treatments for various cancers. Its primary therapeutic agent is Radspherin, an alpha-emitting radiotherapeutic, which is currently undergoing investigation in two Phase 1/2a and one randomized Phase 2 clinical trials. This promising candidate is designed to target and treat malignancies that have metastasized to body cavities, specifically including the peritoneum.
Aksjekurs
$7.09
Sist synkronisert: 2026-10-20
Markedsverdi
$31.73M
Endring (1 dag)
0.30%
Endring (1 år)
6,326.07%
Land
NO
Handel Oncoinvent ASA (ONCIN)
Kategori
Healthcare
Historikk for aksjesplitt for Oncoinvent ASA (ONCIN)
Aksjen Oncoinvent ASA (symbol: ONCIN) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én ONCIN-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 ONCIN-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én ONCIN-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 ONCIN-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
